Smart Capital Traders
  • Politics
  • Investing
  • Latest News
  • Stocks

Smart Capital Traders

  • Politics
  • Investing
  • Latest News
  • Stocks
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post
5 Biggest Blockchain ETFs in 2025
next post
Meghan, Duchess of Sussex shares rare photos of Lilibet in birthday post

related articles

Oil and Gas Price Update: Q3 2025 in...

October 8, 2025

Gold Majors Ride Price Surge to Strong Q2...

August 15, 2025

Crypto Market Recap: Grayscale Debuts Bitcoin ETFs, SEC...

April 4, 2025

Skyharbour Engages Emerging Markets Consulting LLC for Marketing...

November 21, 2025

RETRANSMISSION: Group Eleven to be Featured on Radius...

May 9, 2025

Tech 5: NVIDIA Results Rattle Investors, Trump Signals...

August 31, 2025

Newmont Completes Divestitures With US$425 Million Sale to...

January 28, 2025

Apple announces executive transitions

December 5, 2025

Silver Miners Deliver Record Q2 Earnings as Price...

August 20, 2025

Radiopharm Theranostics

January 11, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Most Popular

    • 1

      Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions

      October 19, 2024
    • 2

      Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results

      October 15, 2024
    • 3

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 4

      Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

      October 31, 2024
    • 5

      As North Korea, Iran and China support Russia’s war, is a ‘new axis’ emerging?

      October 25, 2024

    Categories

    • Investing (3,716)
    • Latest News (2,300)
    • Politics (4,595)
    • Stocks (1,368)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smartcapitaltraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartcapitaltraders.com | All Rights Reserved